Quest Diagnostics, Inc. DGX

NYS: DGX | ISIN: US74834L1008   3/07/2025
176,92 USD (+0,18%)
(+0,18%)   3/07/2025

15 mei 2025 · Quest Diagnostics Declares Quarterly Cash Dividend · Persbericht

13 mei 2025 · Oncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds · Persbericht

22 april 2025 · Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025 · Persbericht

9 april 2025 · Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease · Persbericht

2 april 2025 · Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening · Persbericht

1 april 2025 · Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025 · Persbericht

19 maart 2025 · Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day · Persbericht

18 maart 2025 · Quest Diagnostics to Collaborate with Google Cloud to Streamline Data and Personalize Customer Experiences Using Generative AI · Persbericht

28 augustus 2024 · Quest Diagnostics to Speak at the Morgan Stanley 22nd Annual Global Healthcare Conference · Persbericht

26 augustus 2024 · Quest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation · Persbericht

21 augustus 2024 · Quest Diagnostics to Acquire University Hospitals' Outreach Laboratory Services Business · Persbericht

16 augustus 2024 · Quest Diagnostics Prices $1.85 Billion of Senior Notes · Persbericht

15 augustus 2024 · questhealth.com Introduces 13 New Blood Tests to Identify Micronutrient Deficiencies · Persbericht

15 augustus 2024 · Quest Diagnostics Declares Quarterly Cash Dividend · Persbericht

12 augustus 2024 · Pregnant Women Undertested for STIs, Finds Quest Diagnostics Health Trends® Study of Over 4 Million Pregnancies · Persbericht

1 augustus 2024 · Quest Diagnostics Named a "Best Place to Work for Disability Inclusion" for Seventh Straight Year · Persbericht

29 juli 2024 · Haystack Oncology and Université de Montréal's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal Cancer · Persbericht

25 juli 2024 · BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases · Persbericht

23 juli 2024 · Quest Diagnostics Reports Second Quarter 2024 Financial Results; Raises Guidance for Full Year 2024 · Persbericht

10 juli 2024 · Quest Diagnostics to Acquire Outreach Laboratory Services of OhioHealth · Persbericht

Mijn selecties